Apnimed Q3 EPS $(1.05) Misses $(0.59) Estimate, Sales $2.480M Down From $8.802M YoY
Benzinga Newsdesk 1 day ago
NewsEarningsEarnings Misses
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Apnimed (NASDAQ:APMD) reported quarterly losses of $(1.05) per share which missed the analyst consensus estimate of $(0.59) by 77.97 percent. This is a 42.62 percent increase over losses of $(1.83) per share from the
Apnimed (NASDAQ:APMD) reported quarterly losses of $(1.05) per share which missed the analyst consensus estimate of $(0.59) by 77.97 percent. This is a 42.62 percent increase over losses of $(1.83) per share from the same period last year. The company reported $2.480 million in sales this quarter. This is a 71.82 percent decrease over sales of $8.802 million the same period last year.
